monoclonals

//monoclonals

Human Mouse and Rat Anti cytokine and Anti chemokine monoclonal antibodies

  • Applications::

    ELISA: This antibody can be used as capture antibody at 4-8 μg/mL jointly with biotinylated Anti CXCL10 polyclonal detection antibody to detect Human IP-10. The detection limit for recombinant Human CXCL10 is approxi

  • Applications::

    ELISA: This antibody can be used as capture antibody at 4-8 μg/mL jointly with biotinylated Anti IL15 polyclonal detection antibody to detect Human Interleukin-15. The detection limit for recombinant Human IL-15 is a

  • Applications::

    ELISA: This antibody can be used as capture antibody at 8-10 μg/mL jointly with biotinylated Anti IL10 polyclonal detection antibody to detect Human Interleukin-10. The detection limit for recombinant Human IL-10 is

  • Applications::

    ELISA: This antibody can be used as capture antibody at 1-2 μg/mL jointly with biotinylated Anti IL7 polyclonal detection antibody to detect Human Interleukin-7. The detection limit for recombinant Human IL-7 is appr

  • Applications::

    ELISA: This antibody can be used as capture antibody at 2 μg/mL jointly with biotinylated Anti IL3 polyclonal detection antibody to detect Human Interleukin-3. The detection limit for recombinant Human IL-3 is approx

  • Applications::

    ELISA: This antibody can be used as capture antibody at 2 μg/mL jointly with biotinylated Anti IFN-a polyclonal detection antibody to detect Human IFN-alpha. The detection limit for recombinant Human IFNA is approxim

  • Applications::

    ELISA: This antibody can be used as capture antibody at 2 μg/mL jointly with biotinylated Anti GCSF polyclonal detection antibody to detect Human GCSF. The detection limit for recombinant Human G-CSF is approximately

  • Applications::

    ELISA: This antibody can be used as capture antibody at 2 μg/mL jointly with biotinylated Anti Adiponectin polyclonal detection antibody to detect Human Adiponectin. The detection limit for recombinant Human BAFF is

  • Applications::

    ELISA:This antibody can be used at 2 μg/mLwith the appropriate secondary reagents to detect MDC/CCL22. The detection limit for recombinant human CCL22 is approximately 0.1 ng/well.

    Source::This antibody was produ
  • Applications::

    ELISA:This antibody can be used at 2 μg/mLwith the appropriate secondary reagents to detect TRAIL/APO2L. The detection limit for recombinant human TRAIL is approximately 0.2 ng/well.

    Source::This antibody was prod
  • Applications::

    ELISA:This antibody can be used at 3 μg/mLwith the appropriate secondary reagents to detect MIP-3a/CCL20. The detection limit for recombinant human CCL20 is approximately 0.2 ng/well.

    Source::This antibody was pro
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD16a,CD16b. A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produce
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD130 . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced fro
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD2 . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced from
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD3 . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced from
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD27 . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced from
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD33 . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced from
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD71 . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced from
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD42b . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD20 . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced from
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD9 . A suitable range of concentrations of this antibody for WB detection is 0.5-2.0 µg/ml.

    Source::This antibody was produced
  • Applications::

    Flow Cytometry: This antibody can be used at 0.2 - 1 μg/106cells.

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD41 . A suitable range of concentrations of this antibody for W

  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human CD15 . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced
  • Applications::

    ELISA: This antibody can be used as capture antibody at 5 μg/mL jointly with biotinylated antigen affinity purified Anti BAFF polyclonal antibody to detect Human BAFF. The detection limit for recombinant Human BAFF is

  • Applications::

    ELISA:This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Eotaxin-3.

    Neutralization:To yield one-half maximal inhibition [ND50] of the biological activity of Eotaxin-3 (

  • Applications::

    ELISA:This antibody can be used at 4μg/ml with the appropriate secondary reagents to detect human NAP-2. The detection limit for recombinant NAP-2 is approximately 0.2 ng/well.

    Source::This antibody was produced
  • Applications::

    ELISA: This antibody can be used at 0.5-1μg/mLwith theappropriate secondaryreagents to detect FGF-acidic. The detection limit for FGF-acidic is approximately 2ng/well.

    Western blot:This monoclonal antibody ha

  • Applications::

    ELISA:This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Eotaxin-2. The detection limit for Human Eotaxin-2 is approximately 8 pg/well.

    Source::This antibody was produced f
  • Applications::

    Western blot:This monoclonal antibody has been tested in WB analysis of human RANKL . A suitable range of concentrations of this antibody for WB detection is 0.5-2 µg/ml.

    Source::This antibody was produced
  • Applications::

    Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity of IL-1b (10 µg/ml), a concentration of 4-8 µg/ml of this antibody is required.

    ELISA:This antibody can be u

  • Applications::

    ELISA:This antibody can be used at 4 μg/mL with the appropriate secondary reagents to detect human VEGF. The detection limit for recombinant human VEGF is approximately 0.2 ng/well.

    Source::This antibody was prod
  • Applications::

    ELISA:This antibody can be used at 2 μg/ml with the appropriate secondary reagents to detect human NGF-beta. The detection limit for recombinant beta NGF is approximately 0.1 ng/well.

    Source::This antibody was pr
  • Applications::

    Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity of IL-11 (5µg/ml), a concentration of 2 - 4 µg/ml of this antibody is required.

    ELISA:This antibody can be u

  • Applications::

    ELISA:This antibody can be used at 3 μg/mLwith the appropriate secondary reagents to detect MIP-3b/CCL19. The detection limit for recombinant human CCL19 is approximately 0.2 ng/well.

    Source::This antibody was pr